These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 28412731

  • 1. C-terminal binding protein-2 promotes cell proliferation and migration in breast cancer via suppression of p16INK4A.
    Yang X, Sun Y, Li H, Shao Y, Zhao D, Yu W, Fu J.
    Oncotarget; 2017 Apr 18; 8(16):26154-26168. PubMed ID: 28412731
    [Abstract] [Full Text] [Related]

  • 2. High expression and prognostic role of CAP1 and CtBP2 in breast carcinoma: associated with E-cadherin and cell proliferation.
    Liu X, Yao N, Qian J, Huang H.
    Med Oncol; 2014 Mar 18; 31(3):878. PubMed ID: 24522810
    [Abstract] [Full Text] [Related]

  • 3. CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16INK4A.
    Guan C, Shi H, Wang H, Zhang J, Ni W, Chen B, Hou S, Yang X, Shen A, Ni R.
    J Cell Biochem; 2013 Jun 18; 114(6):1343-54. PubMed ID: 23255392
    [Abstract] [Full Text] [Related]

  • 4. CtBP2 overexpression promotes tumor cell proliferation and invasion in gastric cancer and is associated with poor prognosis.
    Dai F, Xuan Y, Jin JJ, Yu S, Long ZW, Cai H, Liu XW, Zhou Y, Wang YN, Chen Z, Huang H.
    Oncotarget; 2017 Apr 25; 8(17):28736-28749. PubMed ID: 28404932
    [Abstract] [Full Text] [Related]

  • 5. Interaction with cyclin H/cyclin-dependent kinase 7 (CCNH/CDK7) stabilizes C-terminal binding protein 2 (CtBP2) and promotes cancer cell migration.
    Wang Y, Liu F, Mao F, Hang Q, Huang X, He S, Wang Y, Cheng C, Wang H, Xu G, Zhang T, Shen A.
    J Biol Chem; 2013 Mar 29; 288(13):9028-34. PubMed ID: 23393140
    [Abstract] [Full Text] [Related]

  • 6. Down-regulation of C-terminal binding protein 2 (CtBP2) inhibits proliferation, migration, and invasion of human SHSY5Y cells in vitro.
    Nan J, Guan S, Jin X, Jian Z, Linshan F, Jun G.
    Neurosci Lett; 2017 Apr 24; 647():104-109. PubMed ID: 28179207
    [Abstract] [Full Text] [Related]

  • 7. Up-regulation of ceRNA TINCR by SP1 contributes to tumorigenesis in breast cancer.
    Liu Y, Du Y, Hu X, Zhao L, Xia W.
    BMC Cancer; 2018 Apr 03; 18(1):367. PubMed ID: 29614984
    [Abstract] [Full Text] [Related]

  • 8. CtBP2 promotes proliferation and reduces drug sensitivity in non-small cell lung cancer via the Wnt/β-catenin pathway.
    Wang DP, Gu LL, Xue Q, Chen H, Mao GX.
    Neoplasma; 2018 Nov 15; 65(6):888-897. PubMed ID: 30334447
    [Abstract] [Full Text] [Related]

  • 9. Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance.
    Birts CN, Harding R, Soosaipillai G, Halder T, Azim-Araghi A, Darley M, Cutress RI, Bateman AC, Blaydes JP.
    Biol Cell; 2010 Jan 15; 103(1):1-19. PubMed ID: 20964627
    [Abstract] [Full Text] [Related]

  • 10. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
    Griffin NI, Sharma G, Zhao X, Mirza S, Srivastava S, Dave BJ, Aleskandarany M, Rakha E, Mohibi S, Band H, Band V.
    Breast Cancer Res; 2016 Nov 16; 18(1):113. PubMed ID: 27852327
    [Abstract] [Full Text] [Related]

  • 11. Targeting P16INK4A in uterine serous carcinoma through inhibition of histone demethylation.
    Xiao Z, He Y, Liu C, Xiang L, Yi J, Wang M, Shen T, Shen L, Xue Y, Shi H, Liu P.
    Oncol Rep; 2019 May 16; 41(5):2667-2678. PubMed ID: 30896884
    [Abstract] [Full Text] [Related]

  • 12. AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signaling.
    Li J, Guo Y, Duan L, Hu X, Zhang X, Hu J, Huang L, He R, Hu Z, Luo W, Tan T, Huang R, Liao D, Zhu YS, Luo DX.
    Oncotarget; 2017 May 16; 8(20):33694-33703. PubMed ID: 28402270
    [Abstract] [Full Text] [Related]

  • 13. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA, Huang WC, Lee WH, Wu A, Wang LS, Hsiao M, Yeh CT, Chao TY.
    BMC Cancer; 2016 Feb 25; 16():160. PubMed ID: 26917489
    [Abstract] [Full Text] [Related]

  • 14. CtBP2 interacts with ZBTB18 to promote malignancy of glioblastoma.
    Chen L, Wang L, Qin J, Wei DS.
    Life Sci; 2020 Dec 01; 262():118477. PubMed ID: 32971103
    [Abstract] [Full Text] [Related]

  • 15. Citron kinase (CIT-K) promotes aggressiveness and tumorigenesis of breast cancer cells in vitro and in vivo: preliminary study of the underlying mechanism.
    Meng D, Yu Q, Feng L, Luo M, Shao S, Huang S, Wang G, Jing X, Tong Z, Zhao X, Liu R.
    Clin Transl Oncol; 2019 Jul 01; 21(7):910-923. PubMed ID: 30565087
    [Abstract] [Full Text] [Related]

  • 16. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
    Chen J, Shin VY, Siu MT, Ho JC, Cheuk I, Kwong A.
    BMC Cancer; 2016 Nov 14; 16(1):887. PubMed ID: 27842518
    [Abstract] [Full Text] [Related]

  • 17. CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Zheng X, Song T, Dou C, Jia Y, Liu Q.
    Oncotarget; 2015 Feb 28; 6(6):3752-69. PubMed ID: 25686837
    [Abstract] [Full Text] [Related]

  • 18. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
    Debiais-Delpech C, Godet J, Pedretti N, Bernard FX, Irani J, Cathelineau X, Cussenot O, Fromont G.
    Urol Oncol; 2014 May 28; 32(4):426-32. PubMed ID: 24332637
    [Abstract] [Full Text] [Related]

  • 19. Amyloid-β precursor protein promotes cell proliferation and motility of advanced breast cancer.
    Lim S, Yoo BK, Kim HS, Gilmore HL, Lee Y, Lee HP, Kim SJ, Letterio J, Lee HG.
    BMC Cancer; 2014 Dec 10; 14():928. PubMed ID: 25491510
    [Abstract] [Full Text] [Related]

  • 20. Low spinophilin expression enhances aggressive biological behavior of breast cancer.
    Schwarzenbacher D, Stiegelbauer V, Deutsch A, Ress AL, Aigelsreiter A, Schauer S, Wagner K, Langsenlehner T, Resel M, Gerger A, Ling H, Ivan C, Calin GA, Hoefler G, Rinner B, Pichler M.
    Oncotarget; 2015 May 10; 6(13):11191-202. PubMed ID: 25857299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.